Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Tim Pearson
CEO, CARRICK THERAPEUTICS
Early to Mid-Stage Biotechs: Creating Partnerships to Enhance Program Value and Accelerate Therapies
Pete Pellerito
SENIOR POLICY ADVISER FEDERAL/STATE ECONOMIC DEVELOPMENT & TECHNOLOGY TRANSFER LEAD, BIO
Using the Power of Public Funded Research To Drive Innovation and Build a Bioscience Economy: A Discussion with the CIRM & CPRIT
Li Peng, PhD
CHIEF SCIENTIFIC OFFICER, PALLEON PHARMACEUTICALS
Oncology Drug Discovery: Novel Approaches To Drug Discovery
Lucy Pérez, PhD
SENIOR PARTNER, MCKINSEY & COMPANY
Women and Their Health: Fueling an Ecosystem of Scientific Innovation to Address Unmet Needs
Óscar Pérez Albet, MBA
CHIEF MARKETING, MARKET ACCESS, AND BUSINESS OFFICER, FERRER INTERNACIONAL, S.A.
Ferrer Internacional
Barcelona, Spain
Gregory Petsko
PROFESSOR OF NEUROLOGY, ANN ROMNEY CENTER FOR NEUROLOGIC DISEASES HARVARD MEDICAL SCHOOL AND BRIGHAM & WOMEN’S HOSPITAL
AI For Good: Making sense of big data and high tech to Cure What Ails Us
Jennifer Petter, PhD
FOUNDER AND CSO, ARRAKIS THERAPEUTICS, INC
Investing in the Value of DEI for Your Company and Community
Waltham, Massachusetts, United States
Allen Phelps, CFE,CPP
CEO, IPTALONS, INC.
Protecting Trade Secrets from the Growing Foreign Influence Threat to Early Stage Discovery Programs
Dallas, Texas, United States
Alex Philippidis
SENIOR BUSINESS EDITOR, GENETIC ENGINEERING & BIOTECHNOLOGY
Perspectives on Target Selection: How Companies Approach a Critical Decision
Waranyoo Phoolcharoen
CHIEF TECHNOLOGY OFFICER AND CO-FOUNDER, BAIYA PHYTOPHARM. CO., LTD
Baiya Phytopharm. Co., Ltd
Bangkok, Thailand